GR1002332B - Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. - Google Patents

Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.

Info

Publication number
GR1002332B
GR1002332B GR930100197A GR930100197A GR1002332B GR 1002332 B GR1002332 B GR 1002332B GR 930100197 A GR930100197 A GR 930100197A GR 930100197 A GR930100197 A GR 930100197A GR 1002332 B GR1002332 B GR 1002332B
Authority
GR
Greece
Prior art keywords
simethicone
novel
pharmaceutical compositions
containing pharmaceutical
loperamide
Prior art date
Application number
GR930100197A
Other languages
Greek (el)
English (en)
Other versions
GR930100197A (el
Inventor
Edward J. Roche
Michael R. Hoy
Stevens A. Charles
Original Assignee
Mcneil-Ppc Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26715151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR1002332(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil-Ppc Inc. filed Critical Mcneil-Ppc Inc.
Publication of GR930100197A publication Critical patent/GR930100197A/el
Publication of GR1002332B publication Critical patent/GR1002332B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR930100197A 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. GR1002332B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88720792A 1992-05-21 1992-05-21
US3839793A 1993-03-29 1993-03-29

Publications (2)

Publication Number Publication Date
GR930100197A GR930100197A (el) 1994-01-31
GR1002332B true GR1002332B (el) 1996-05-16

Family

ID=26715151

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100197A GR1002332B (el) 1992-05-21 1993-05-17 Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.

Country Status (7)

Country Link
US (4) US5599577A (fr)
EP (1) EP0571217B1 (fr)
BR (1) BR1100507A (fr)
CA (1) CA2096575C (fr)
DE (1) DE69315257T2 (fr)
ES (1) ES2112387T3 (fr)
GR (1) GR1002332B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773866B1 (fr) * 1994-08-03 1998-04-08 Gunter Meinhardt Voss Procede de fabrication de comprimes enrobes
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US6537525B1 (en) 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US6100245A (en) * 1999-09-07 2000-08-08 Mcneil-Ppc, Inc. Use of simethicone to treat ulcerative colitis
HK1050135A1 (zh) 1999-11-02 2003-06-13 Depomed, Inc. 用於促进将药物给予胃的饭後模式药理学诱导
DK1294372T3 (da) * 2000-06-23 2005-09-19 Bioprojet Soc Civ Törpulverformulering der omdanner racecadotril
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6669271B2 (en) * 2001-06-22 2003-12-30 East Manufacturing Corporation Smooth side body structure and method
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7096533B2 (en) * 2004-06-12 2006-08-29 Kruegar International, Inc. Locking roller for an article of furniture
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7535175B1 (en) * 2006-02-16 2009-05-19 Imaging Systems Technology Electrode configurations for plasma-dome PDP
EP1992345A4 (fr) * 2006-03-09 2010-07-28 Espinoza Abdala Leopoldo De Je Combinaison synergique d'inhibiteurs des récepteurs h2, de silicone inerte et d'un complexe d'aluminate d'hydroxymagnésium
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient
US7754041B2 (en) * 2006-07-31 2010-07-13 3M Innovative Properties Company Pleated filter with bimodal monolayer monocomponent media
US7662373B2 (en) * 2006-09-18 2010-02-16 Thompson Ronald J Method and composition of a medicament to decrease the adverse events of Olistat, an oral lipase inhibitor
WO2008056200A1 (fr) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Compositions pharmaceutiques orales de siméthicone
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
EP2797600A4 (fr) 2011-12-28 2015-09-16 Pozen Inc Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
WO2016200345A1 (fr) 2015-06-12 2016-12-15 Santa Farma İlaç Sanayi̇ A. Ş. Composition pharmaceutique orale comprenant du bromure d'otilonium et de la siméthicone présentant une certaine densité en vrac et des caractéristiques de dissolution améliorées
WO2017106812A1 (fr) 2015-12-19 2017-06-22 First Time Us Generics Llc Formulations pharmaceutiques de comprimés mous à mâcher
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3687502B1 (fr) 2017-09-29 2023-06-07 Johnson & Johnson Consumer Inc. Particules solides de siméthicone et leur forme posologique
BR112020016884A2 (pt) * 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
GR1009632B (el) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
WO2022200897A1 (fr) * 2021-03-24 2022-09-29 Johnson & Johnson Consumer Inc. Composition pharmaceutique comprenant de la famotidine
JP2024544741A (ja) * 2021-11-16 2024-12-03 ジョンソン アンド ジョンソン コンシューマー インク． シメチコンを含有するカスタマイズ可能な剤形
CA3246974A1 (fr) * 2022-04-01 2023-10-05 EMPLICURE AB (publ) Produits intra-buccaux alcalins

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
DE2517585A1 (de) * 1974-05-16 1975-11-27 Hoffmann La Roche Heilmittel
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
CA1139221A (fr) * 1978-10-10 1983-01-11 Vijay B. Surpuriya Anti-acide
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4428927A (en) * 1981-05-11 1984-01-31 R. P. Scherer Corporation Masticatory soft elastic gelatin capsules and method for the manufacture thereof
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4857324A (en) * 1985-10-08 1989-08-15 American Home Products Corporation (Del.) Exogenously acidified antacid compositions having cytoprotective properties
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
EP0294933B1 (fr) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Compositions pharmaceutiques
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
IN171919B (fr) * 1989-11-01 1993-02-06 Mcneil Ppc Inc
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
US5447918A (en) * 1992-07-27 1995-09-05 Mccullough; Ricky W. Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2110313C (fr) * 1992-12-01 2004-10-26 Edward John Roche Compositions pharmaceutiques contenant un compose de guanidothiazole et antiacides

Also Published As

Publication number Publication date
DE69315257D1 (de) 1998-01-02
DE69315257T2 (de) 1998-05-14
US5679376A (en) 1997-10-21
ES2112387T3 (es) 1998-04-01
GR930100197A (el) 1994-01-31
EP0571217A2 (fr) 1993-11-24
US5980944A (en) 1999-11-09
CA2096575A1 (fr) 1993-11-22
BR1100507A (pt) 2002-04-02
US5716641A (en) 1998-02-10
CA2096575C (fr) 2003-05-13
EP0571217A3 (en) 1994-06-01
US5599577A (en) 1997-02-04
EP0571217B1 (fr) 1997-11-19

Similar Documents

Publication Publication Date Title
GR1002332B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
DK0600725T3 (da) Farmaceutiske præparater indeholdende en guanidinothiazolforbindelse og antacider
IT8220781A0 (it) Bifosfonati farmacologicamente attivi, procedimento per la loro preparazione e relative composizioni farmaceutiche.
DK488287A (da) Farmaceutisk praeparat
CA2238271A1 (fr) Compositions pharmaceutiques comprenant du flurbiprofene
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
CA2038744A1 (fr) Composition pharmaceutique contenant un medicament legerement hydrosoluble
IL65328A (en) Pharmaceutical compositions comprising a calcium-antagonistic gallopamil or verapamil and their preparation
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IL62197A (en) Imino-prostacyclines,their preparation and pharmaceutical compositions containing them
CA2078869A1 (fr) Compositions pharmaceutiques contenant de l'ipriflavone, leur procede de preparation et leur emploi therapeutique relatif
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
EP0093497A3 (fr) Traitement anthelminthique
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IT8221678A0 (it) Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
ES519605A0 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
EP0015721A1 (fr) Composition pour l'arthrite rhumatoide et d'autres états arthritiques et procédé pour sa préparation
IT8221679A0 (it) Composti idrossiminici e alcossiminici ad attivita'calcioantagonista, procedimento per la loro preparazione e relative composizioni farmaceutiche.
EP0039874A3 (fr) Compositions à base de méthoxsalen et leur préparation
FR2602679B1 (fr) Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees